GlassScriptPhysician profile
Radhalakshmi D Aluru
NPI 1376757260
$1,164.91
in general payments reported to CMS, 2019-2025
15 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $14.55 · 2021: $51.80 · 2022: $94.76 · 2023: $369 · 2024: $314 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $883.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $475.28 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $160.46 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $113.91 | 2024-2025 | |
| Abbott Laboratories | $73.75 | 2024-2025 | Lamitrode, Eterna, Octrode |
| Otsuka America Pharmaceutical, INC. | $59.84 | 2023-2025 | Rexulti |
| Exact Sciences Corporation | $59.74 | 2023-2024 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $40.89 | 2022-2023 | Quviviq |
| Glaxosmithkline, LLC. | $39.61 | 2023 | Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.88 | 2019 | |
| Photonicare INC | $20.34 | 2025 | Otosight Middle Ear Scope |
| Cardiovascular Systems INC. | $18.76 | 2019 | |
| Boston Scientific Corporation | $18.25 | 2024 | Wavewriter Alpha Prime 16 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.22 | 2024 | Caplyta |
| Masimo Corporation | $17.28 | 2023 | Patient Safetynet System |
| Dexcom, INC. | $15.70 | 2024 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Radhalakshmi Aluru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.